Korea lays focus on AI-based seizure detection medical device

Seoul National University Bundang Hospital (SNUBH) presented its preliminary study result of seizure monitoring for pati...

December 6, 2022 | Tuesday | News
SK Biopharmaceuticals appoints new CEO

South Korea-based SK Biopharmaceuticals has named Donghoon Lee, Executive Vice President and Head of Bio Investment Cent...

December 1, 2022 | Thursday | News
Korea develops highly productive bioprocessing system

Bioprocesses, meant for increasing the number of living cells or other biologic systems/components such as bacteria, vir...

November 29, 2022 | Tuesday | News
Everest Medicines announces major regulatory updates in Taiwan and South Korea

China-based biopharma firm Everest Medicines has announced that the Taiwan Food and Drug Administration and Ministry of ...

November 28, 2022 | Monday | News
IVI, ST Pharm exchange MoU on clinical development of COVID-19 vaccine

The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...

November 25, 2022 | Friday | News
Biovac, IVI to develop & manufacture oral cholera vaccine for African and global markets

South African based biopharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer a...

November 24, 2022 | Thursday | News
Lunit accelerates AI-powered medical imaging across major overseas channels

South Korea-based startup Lunit has signed a global distribution agreement with Indian firm CARPL.ai, an end-to-end heal...

November 24, 2022 | Thursday | News
SK bioscience announces KRW 3 Bn donation to IVI to support advancement of global vaccine R&D

SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...

November 18, 2022 | Friday | News
Korea inks MoU with US to establish precision medicine research platform

Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...

November 17, 2022 | Thursday | News
Oramed signs deal with Medicox to commercialise oral insulin in South Korea

Oramed Pharmaceuticals, a US and Israel-based clinical-stage pharmaceutical company focused on the development of oral d...

November 15, 2022 | Tuesday | News
Korean CRO expands partnership with Medidata to enhance clinical operations

US-based Medidata, a Dassault Systèmes company, has announced that C&R Research, the largest Korean CRO, has ...

November 16, 2022 | Wednesday | News
Korea Drug Development Fund invests in novel oncology candidate

South Korea-based SK Biopharmaceuticals has announced that the state-run Korea Drug Development Fund (KDDF) has decided ...

November 15, 2022 | Tuesday | News
Lemonex, IVI exchange MoU on joint vaccine development in Korea

The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...

November 14, 2022 | Monday | News
TAE Life Sciences to launch cancer radiation therapy in South Korea

US-based TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutr...

November 11, 2022 | Friday | News
Alpinion Medical Systems introduces latest intelligent ultrasound technology

Alpinion Medical Systems, a subsidiary of South Korea-based ILJIN Group, plans to present a new range of high-performanc...

November 10, 2022 | Thursday | News
SK bioscience announces new strategy for continuous growth

South Korea-based SK bioscience has announced a future growth strategy to secure global top-tier vaccine development cap...

November 7, 2022 | Monday | News
Ono Pharma receives approval for mAb treatment of NSCLC in South Korea

Japan's Ono Pharmaceutical has announced that its Korean subsidiary of ONO, has received the approval of Opdivo (nivol...

October 30, 2022 | Sunday | News
Eucure Biopharma partners with ISU ABXIS to develop cancer drugs

Eucure Biopharma, a China-based clinical-stage biotechnology startup focused on the development of antibody therapeutics...

November 1, 2022 | Tuesday | News